메뉴 건너뛰기




Volumn 69, Issue 6, 2013, Pages 344-345

Tacrolimus monotherapy: A promising option for ocular myasthenia gravis

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; CHOLINESTERASE INHIBITOR; TACROLIMUS;

EID: 84875636256     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000347068     Document Type: Letter
Times cited : (21)

References (9)
  • 1
    • 53049086856 scopus 로고    scopus 로고
    • Current and future standards in treatment of myasthenia gravis
    • Gold R, Schneider-Gold C: Current and future standards in treatment of myasthenia gravis. Neurotherapeutics 2008; 5: 535-541.
    • (2008) Neurotherapeutics , vol.5 , pp. 535-541
    • Gold, R.1    Schneider-Gold, C.2
  • 2
    • 44949109211 scopus 로고    scopus 로고
    • Steroids and immunosuppressant drugs in myasthenia gravis
    • Sathasivam S: Steroids and immunosuppressant drugs in myasthenia gravis. Nat Clin Pract Neuro 2008; 4: 317-327.
    • (2008) Nat Clin Pract Neuro , vol.4 , pp. 317-327
    • Sathasivam, S.1
  • 3
    • 18144429444 scopus 로고    scopus 로고
    • Long-term results of tacrolimus in cyclosporine-And prednisone-dependent myasthenia gravis
    • Ponseti JM, Azem J, Fort JM, López-Cano M, Vilallonga R, Buera M, et al: Long-term results of tacrolimus in cyclosporine-And prednisone-dependent myasthenia gravis. Neurology 2005; 64: 1641-1643.
    • (2005) Neurology , vol.64 , pp. 1641-1643
    • Ponseti, J.M.1    Azem, J.2    Fort, J.M.3    López-Cano, M.4    Vilallonga, R.5    Buera, M.6
  • 4
    • 33748030791 scopus 로고    scopus 로고
    • Mycophenolate mofetil and tacrolimus: New therapeutic options in neuroimmunological diseases
    • Schneider-Gold C, Hartung HP, Gold R: Mycophenolate mofetil and tacrolimus: new therapeutic options in neuroimmunological diseases. Muscle Nerve 2006; 34: 284-291.
    • (2006) Muscle Nerve , vol.34 , pp. 284-291
    • Schneider-Gold, C.1    Hartung, H.P.2    Gold, R.3
  • 5
    • 0242331696 scopus 로고    scopus 로고
    • Japanese fk506 mg study group: Clinical study of fk506 in patients with myasthenia gravis
    • Konishi T, Yoshiyama Y, Takamori M, Yagi K, Mukai E, Saida T; Japanese FK506 MG Study Group: Clinical study of FK506 in patients with myasthenia gravis. Muscle Nerve 2003; 28: 570-574.
    • (2003) Muscle Nerve , vol.28 , pp. 570-574
    • Konishi, T.1    Yoshiyama, Y.2    Takamori, M.3    Yagi, K.4    Mukai, E.5    Saida, T.6
  • 6
    • 55449109232 scopus 로고    scopus 로고
    • Treatment of ocular symptoms in myasthenia gravis
    • Bhanushali MJ, Wuu J, Benatar M: Treatment of ocular symptoms in myasthenia gravis. Neurology 2008; 71: 1335-1341.
    • (2008) Neurology , vol.71 , pp. 1335-1341
    • Bhanushali, M.J.1    Wuu, J.2    Benatar, M.3
  • 7
    • 76649084529 scopus 로고    scopus 로고
    • Factors associated with response to calcineurin inhibitors in myasthenia gravis
    • Nagane Y, Suzuki S, Suzuki N, Utsugisawa K: Factors associated with response to calcineurin inhibitors in myasthenia gravis. Muscle Nerve 2010; 41: 212-218.
    • (2010) Muscle Nerve , vol.41 , pp. 212-218
    • Nagane, Y.1    Suzuki, S.2    Suzuki, N.3    Utsugisawa, K.4
  • 9
    • 34250337206 scopus 로고    scopus 로고
    • Quality standards subcommittee of the american academy of neurology: Evidence report: The medical treatment of ocular myasthenia (an evidencebased review): Report of the quality standards subcommittee of the american academy of neurology
    • Benatar M, Kaminski HJ; Quality Standards Subcommittee of the American Academy of Neurology: Evidence report: the medical treatment of ocular myasthenia (an evidencebased review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2007; 68: 2144-2149.
    • (2007) Neurology , vol.68 , pp. 2144-2149
    • Benatar, M.1    Kaminski, H.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.